Weight Management clinical trials

Explore recruiting weight management clinical trials.

Recruiting weight management studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Weight Management trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, Phase 2, dose-finding trial of once weekly petrelintide compared with placebo in participants with obesity or overweight with weight related comorbidities

Poland, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

A single and multiple dose trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of ZP6590

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A clinical research study investigating how the body processes the new compound petrelintide in people with kidney problems

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A clinical study of MK-4082 in healthy people (MK-4082-001)

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)

Hungary, Italy, Czechia, Germany, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Weight Management trials by city

Weight Management in Toronto Weight Management in Vancouver Weight Management in Montreal Weight Management in Calgary Weight Management in Edmonton Weight Management in Ottawa Weight Management in Winnipeg Weight Management in Quebec City Weight Management in Hamilton Weight Management in Kitchener Weight Management in London Weight Management in Halifax Weight Management in New York Weight Management in Los Angeles Weight Management in Chicago Weight Management in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease